http://www.reportlinker.com/report/search/isAdwords//isCountryAdwords//theme/testosterone_gel Wed, 22 May 2013 10:10:03 +0000 helpdesk@reportlinker.com Copyright 2013, Reportlinker Zend_Feed en-us http://blogs.law.harvard.edu/tech/rss http://www.reportlinker.com/d012725016/Drug-and-Medication-in-The-United-States-and-Canada-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d012725016/Drug-and-Medication-in-The-United-States-and-Canada-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Shareholder focused Successful leadership Industry and capital market experience 4 business profile trimel S engineered technology platforms 5 technology description: gel designed to adhere ...]]> Wed, 30 Nov 2011 23:00:00 +0000 http://www.reportlinker.com/d012285833/Pharmaceutical-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d012285833/Pharmaceutical-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Expectations and intentions with respect to future operations and products, future market acceptance, size and potential of libigel and other statements identified by words such as Will, Potential, Could ...]]> Fri, 31 Dec 2010 23:00:00 +0000 http://www.reportlinker.com/d012439136/Sexual-Dysfunction-Market-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d012439136/Sexual-Dysfunction-Market-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Physicians (march / april 2010). (2) Biosante estimate of potential market based on erectile dysfunction sales, testosterone for men sales and current off-label testosterone use, as well as the campbell ...]]> Mon, 28 Feb 2011 23:00:00 +0000 http://www.reportlinker.com/d012190454/Pharmaceutical-in-The-United-States-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d012190454/Pharmaceutical-in-The-United-States-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... With respect to future operations and products, future market acceptance, size and potential of libigel and other statements identified by words such as Would, Will, Potential, Could, Can, Believe ...]]> Fri, 31 Dec 2010 23:00:00 +0000 http://www.reportlinker.com/d012398501/Pharmaceutical-Sector-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d012398501/Pharmaceutical-Sector-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Of satisfying sexual events, and change in the mean desire Secondary endpoint: decrease in distress associated with low desire The spa affirms that the libigel phase iii clinical plan is acceptable ...]]> Fri, 31 Dec 2010 23:00:00 +0000 http://www.reportlinker.com/d012170972/Pharmaceutical-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d012170972/Pharmaceutical-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Expectations and intentions with respect to future operations and products, future market acceptance, size and potential of libigel and other statements identified by words such as Will, Potential, Could ...]]> Mon, 31 Jan 2011 23:00:00 +0000 http://www.reportlinker.com/d012612004/Vitamin-and-Supplement-Business-in-Japan-and-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d012612004/Vitamin-and-Supplement-Business-in-Japan-and-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... In elders. Keywords: i-10 cells, menaquinone-4, protein kinase a, testis, testosterone, vitamin k background vitamin k acts as the cofactor of g-glutamylcarboxylase, which converts specific glutamate residues ...]]> Sun, 31 Jul 2011 22:00:00 +0000 http://www.reportlinker.com/d013473971/U-S-Pharmaceutical-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d013473971/U-S-Pharmaceutical-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Self-injection will improve patient compliance and deliver sufficient serum testosterone levels The new vibex qs is particularly well-suited for use with highly viscous drugs such as testosterone ...]]> Thu, 31 May 2012 22:00:00 +0000 http://www.reportlinker.com/d012553396/Testosterone-in-Australia-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d012553396/Testosterone-in-Australia-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Around the globe to promote The testosterone therapy market is over $1.5 Billion us dollars and grew at approximately 26% in 2010 Axiron is in a unique position to take advantage ...]]> Sun, 31 Jul 2011 22:00:00 +0000 http://www.reportlinker.com/d013425127/Drug-and-Medication-Market-in-Africa-and-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d013425127/Drug-and-Medication-Market-in-Africa-and-China.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Indications] testosterone patch is applicable for testosterone replacement therapy in male patients with hypogonadia (e.G. Post testectomy, anorchia, orchiditis, klinefelter syndrome, hypopituitarism ...]]> Fri, 31 Dec 2010 23:00:00 +0000